Highlights
- Groundbreaking Nature study reveals brain lithium deficiency is linked to Alzheimer’s disease (AD) onset.
- Lithium orotate supplementation reverses memory loss and brain pathology in AD mouse models, unlike traditional lithium carbonate.
- Lithium orotate is less likely to be sequestered by amyloid plaques and shows no observed toxicity in long-term animal studies.
- Potential implications for AD treatment and broader neuropsychiatric applications, pending human clinical trials.
Study Background and Disease Burden
